Treatment with formoterol/budesonide in patients with asthma
Not Applicable
- Conditions
- Asthma
- Registration Number
- JPRN-UMIN000005185
- Lead Sponsor
- Hamamatsu University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 130
Inclusion Criteria
Not provided
Exclusion Criteria
History of hypersensitivity to budesonide History or presence of lung, cardiac, renal and liver desease Use of systemic corticosteroids
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method FEV1 at week 0 and week 12
- Secondary Outcome Measures
Name Time Method V50 at week 0 and week 12 V25 at week 0 and week 12 FVC at week 0 and week 12 Exhaled NO at week 0 and week 12 Adverse events at week 0 and week 12 Mean rate of all exacerbations at week 0 and week 12